drugset / Trial / NCT03468075
Gemcitabine Plus Ascorbate for Sarcoma in Adults
Phase 2
Terminated
10 enrolled
Mohammed Milhem, MBBS
St. Baldrick's Foundation · collabUniversity of Iowa · collab
NaSingle-groupOpen-labelTreatment
Summary
This study will enroll patients who have a diagnosis of locally advanced, unresectable or metastatic soft tissue or bone sarcoma (except gastrointestinal stromal tumors and Kaposi's sarcoma) from any site.
Timeline
- Start
- 2018-07-11
- Primary completion
- 2019-04-16
- Completion
- 2020-10-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemcitabine | Small molecule | — | — |
| Subject | Vitamin C | Other / unclassified | 75 g | — |